Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.
Andrew B M LimCameron CurleyChun Y FongIan BilmonAshanka BeligaswatteDuncan PurtillBartlomiej GettaAnne M JohnstonTasman ArmytageMarnie CollinsKate MasonKatherine FieldingMatthew GreenwoodJohn GibsonMark HertzbergMatthew WrightIan LewisJohn MooreDavid CurtisJeffrey SzerGlen KennedyDavid RitchiePublished in: Internal medicine journal (2018)
Patients with AML who relapse beyond 6 months from alloHSCT without prior grade 3-4 acute GVHD have a better outcome from salvage therapy. Salvage treatments employing DCT as the initial treatment of AML relapse confer a survival advantage over CT.
Keyphrases
- stem cell transplantation
- prognostic factors
- free survival
- acute myeloid leukemia
- high dose
- liver failure
- allogeneic hematopoietic stem cell transplantation
- respiratory failure
- multiple sclerosis
- bone marrow
- aortic dissection
- drug induced
- computed tomography
- dendritic cells
- low dose
- immune response
- hepatitis b virus
- image quality
- stem cells
- disease activity
- systemic lupus erythematosus
- positron emission tomography
- extracorporeal membrane oxygenation
- mesenchymal stem cells
- combination therapy